CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1CVS - US1266501006 - Common Stock
69.19 EUR
-0.81 (-1.16%)
Overall 1CVS gets a fundamental rating of 4 out of 10. We evaluated 1CVS against 29 industry peers in the Health Care Providers & Services industry. 1CVS has a bad profitability rating. Also its financial health evaluation is rather negative. 1CVS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
1CVS had positive earnings in the past year.
1CVS had a positive operating cash flow in the past year.
In the past 5 years 1CVS has always been profitable.
In the past 5 years 1CVS always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of 1CVS (0.18%) is worse than 67.74% of its industry peers.
Looking at the Return On Equity, with a value of 0.64%, 1CVS is doing worse than 70.97% of the companies in the same industry.
1CVS has a Return On Invested Capital of 4.90%. This is comparable to the rest of the industry: 1CVS outperforms 51.61% of its industry peers.
1CVS had an Average Return On Invested Capital over the past 3 years of 6.22%. This is in line with the industry average of 6.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| ROIC | 4.9% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1.3 Margins
With a Profit Margin value of 0.12%, 1CVS is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
1CVS's Profit Margin has declined in the last couple of years.
1CVS has a worse Operating Margin (2.73%) than 67.74% of its industry peers.
1CVS's Operating Margin has declined in the last couple of years.
The Gross Margin of 1CVS (13.88%) is worse than 64.52% of its industry peers.
1CVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.73% | ||
| PM (TTM) | 0.12% | ||
| GM | 13.88% |
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CVS is destroying value.
Compared to 1 year ago, 1CVS has less shares outstanding
1CVS has less shares outstanding than it did 5 years ago.
1CVS has a worse debt/assets ratio than last year.
2.2 Solvency
1CVS has an Altman-Z score of 2.25. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 1CVS (2.25) is comparable to the rest of the industry.
1CVS has a debt to FCF ratio of 10.46. This is a negative value and a sign of low solvency as 1CVS would need 10.46 years to pay back of all of its debts.
1CVS has a Debt to FCF ratio of 10.46. This is comparable to the rest of the industry: 1CVS outperforms 48.39% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that 1CVS is somewhat dependend on debt financing.
1CVS has a Debt to Equity ratio of 0.85. This is comparable to the rest of the industry: 1CVS outperforms 51.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 10.46 | ||
| Altman-Z | 2.25 |
ROIC/WACC0.62
WACC7.92%
2.3 Liquidity
1CVS has a Current Ratio of 0.83. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.83, 1CVS is in line with its industry, outperforming 41.94% of the companies in the same industry.
1CVS has a Quick Ratio of 0.83. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
1CVS has a Quick ratio of 0.63. This is in the lower half of the industry: 1CVS underperforms 64.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
1CVS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.87%.
1CVS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.20% yearly.
1CVS shows a small growth in Revenue. In the last year, the Revenue has grown by 6.82%.
Measured over the past years, 1CVS shows a small growth in Revenue. The Revenue has been growing by 7.74% on average per year.
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
3.2 Future
Based on estimates for the next years, 1CVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.34% on average per year.
The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y22.97%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
EPS Next 5Y12.34%
Revenue Next Year7.26%
Revenue Next 2Y6.15%
Revenue Next 3Y5.94%
Revenue Next 5Y5%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.83, which indicates a very decent valuation of 1CVS.
Compared to the rest of the industry, the Price/Earnings ratio of 1CVS indicates a rather cheap valuation: 1CVS is cheaper than 83.87% of the companies listed in the same industry.
1CVS is valuated cheaply when we compare the Price/Earnings ratio to 27.00, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 11.23, the valuation of 1CVS can be described as reasonable.
Based on the Price/Forward Earnings ratio, 1CVS is valued cheaply inside the industry as 80.65% of the companies are valued more expensively.
1CVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.83 | ||
| Fwd PE | 11.23 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as 1CVS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.35 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
1CVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1CVS's earnings are expected to grow with 14.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y15.41%
EPS Next 3Y14.66%
5. Dividend
5.1 Amount
1CVS has a Yearly Dividend Yield of 3.42%.
Compared to an average industry Dividend Yield of 1.45, 1CVS pays a better dividend. On top of this 1CVS pays more dividend than 90.32% of the companies listed in the same industry.
1CVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.42% |
5.2 History
The dividend of 1CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
722.81% of the earnings are spent on dividend by 1CVS. This is not a sustainable payout ratio.
The dividend of 1CVS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP722.81%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
BIT:1CVS (1/7/2026, 7:00:00 PM)
69.19
-0.81 (-1.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.68%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap87.83B
Revenue(TTM)394.08B
Net Income(TTM)469.00M
Analysts80.61
Price Target77.36 (11.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.42% |
Yearly Dividend2.26
Dividend Growth(5Y)5.72%
DP722.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.34%
Min EPS beat(2)15.69%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)24.17%
Min EPS beat(4)15.69%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)6.87%
EPS beat(12)10
Avg EPS beat(12)5.67%
EPS beat(16)14
Avg EPS beat(16)5.3%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.97%
Revenue beat(12)9
Avg Revenue beat(12)1.97%
Revenue beat(16)13
Avg Revenue beat(16)2.12%
PT rev (1m)11.07%
PT rev (3m)10.58%
EPS NQ rev (1m)4.24%
EPS NQ rev (3m)5.66%
EPS NY rev (1m)3.6%
EPS NY rev (3m)3.85%
Revenue NQ rev (1m)2.19%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)1.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.83 | ||
| Fwd PE | 11.23 | ||
| P/S | 0.26 | ||
| P/FCF | 16.35 | ||
| P/OCF | 11.29 | ||
| P/B | 1.41 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)5.85
EY8.45%
EPS(NY)6.16
Fwd EY8.91%
FCF(TTM)4.23
FCFY6.12%
OCF(TTM)6.13
OCFY8.85%
SpS265.06
BVpS49.05
TBVpS-25.92
PEG (NY)0.51
PEG (5Y)N/A
Graham Number80.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| ROCE | 6.61% | ||
| ROIC | 4.9% | ||
| ROICexc | 5.26% | ||
| ROICexgc | 19.51% | ||
| OM | 2.73% | ||
| PM (TTM) | 0.12% | ||
| GM | 13.88% | ||
| FCFM | 1.6% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
F-Score6
Asset Turnover1.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 10.46 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.71% | ||
| Interest Coverage | -3.53 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 1341.79% | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 2.25 |
F-Score6
WACC7.92%
ROIC/WACC0.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
EPS Next Y22.97%
EPS Next 2Y15.41%
EPS Next 3Y14.66%
EPS Next 5Y12.34%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
Revenue Next Year7.26%
Revenue Next 2Y6.15%
Revenue Next 3Y5.94%
Revenue Next 5Y5%
EBIT growth 1Y-3.81%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year46.12%
EBIT Next 3Y19.3%
EBIT Next 5Y17.54%
FCF growth 1Y-44.32%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-35.44%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%
CVS HEALTH CORP / 1CVS.MI FAQ
What is the fundamental rating for 1CVS stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1CVS.MI.
What is the valuation status of CVS HEALTH CORP (1CVS.MI) stock?
ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for CVS HEALTH CORP?
CVS HEALTH CORP (1CVS.MI) has a profitability rating of 3 / 10.
How financially healthy is CVS HEALTH CORP?
The financial health rating of CVS HEALTH CORP (1CVS.MI) is 2 / 10.
Is the dividend of CVS HEALTH CORP sustainable?
The dividend rating of CVS HEALTH CORP (1CVS.MI) is 6 / 10 and the dividend payout ratio is 722.81%.